Insider Transactions in Q2 2021 at Guardant Health, Inc. (GH)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2021
|
Ian T Clark Director |
SELL
Open market or private sale
|
Direct |
10,559
-100.0%
|
$1,372,670
$130.0 P/Share
|
|
Jun 29
2021
|
Ian T Clark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,916
+23.63%
|
$236,640
$40.63 P/Share
|
|
Jun 10
2021
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$557,542
$113.6 P/Share
|
|
Jun 10
2021
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
|
May 10
2021
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$656,222
$133.01 P/Share
|
|
May 10
2021
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
|
May 05
2021
|
Samir Kaul Director |
SELL
Open market or private sale
|
Indirect |
5,000
-4.01%
|
$715,000
$143.39 P/Share
|
|
Apr 26
2021
|
Ian T Clark Director |
SELL
Open market or private sale
|
Direct |
538
-10.38%
|
$85,542
$159.92 P/Share
|
|
Apr 26
2021
|
Ian T Clark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
538
+9.41%
|
$2,152
$4.18 P/Share
|
|
Apr 26
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
751
-0.04%
|
$120,160
$160.01 P/Share
|
|
Apr 23
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,388
-0.4%
|
$1,182,080
$160.12 P/Share
|
|
Apr 21
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
56,358
-0.5%
|
$8,510,058
$151.03 P/Share
|
|
Apr 20
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,007
-0.17%
|
$2,401,050
$150.25 P/Share
|
|
Apr 19
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,932
-0.37%
|
$7,843,528
$154.03 P/Share
|
|
Apr 16
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
51,123
-0.64%
|
$8,077,434
$158.35 P/Share
|
|
Apr 15
2021
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,077
-6.77%
|
$171,243
$159.2 P/Share
|
|
Apr 15
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
157,107
-1.24%
|
$24,822,906
$158.78 P/Share
|
|
Apr 14
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
60,982
-0.55%
|
$9,513,192
$156.32 P/Share
|
|
Apr 13
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
105,806
-0.77%
|
$16,505,736
$156.14 P/Share
|
|
Apr 12
2021
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-14.44%
|
$759,836
$154.28 P/Share
|
|
Apr 12
2021
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
|
Apr 12
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
72,861
-0.61%
|
$11,147,733
$153.97 P/Share
|
|
Apr 09
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
60,996
-0.62%
|
$9,576,372
$157.3 P/Share
|
|
Apr 08
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
122,846
-1.2%
|
$19,655,360
$160.68 P/Share
|
|
Apr 07
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,843
-0.23%
|
$5,858,037
$159.25 P/Share
|
|
Apr 05
2021
|
Samir Kaul Director |
SELL
Open market or private sale
|
Indirect |
5,000
-4.32%
|
$790,000
$158.02 P/Share
|